These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1667284)

  • 1. Differential actions of platelet-activating factor (PAF) receptor antagonists on the vasodilator and vasoconstrictor effects of PAF in the rat perfused heart.
    Hu WM; Man RY
    Br J Pharmacol; 1991 Dec; 104(4):773-5. PubMed ID: 1667284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart.
    Hu W; McNicholl IK; Choy PC; Man RY
    Br J Pharmacol; 1993 Oct; 110(2):645-50. PubMed ID: 8242237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar coronary vascular effects in the rat perfused heart of platelet-activating factor structural analogues with agonist and antagonist properties.
    Man RY; Kinnaird AA
    Br J Pharmacol; 1995 Nov; 116(5):2359-64. PubMed ID: 8581269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of the coronary vascular effects of platelet-activating factor in the rat perfused heart.
    Hu W; Kinnaird AA; Man RY
    Br J Pharmacol; 1991 May; 103(1):1097-102. PubMed ID: 1652337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists.
    Piper PJ; Stewart AG
    Br J Pharmacol; 1987 Apr; 90(4):771-83. PubMed ID: 3034369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of vasoactive substances released by platelet-activating factor in the rat perfused heart.
    Hu WM; Man RY
    Br J Pharmacol; 1991 Dec; 104(4):933-7. PubMed ID: 1810604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary vascular reactivity: effect of PAF and PAF antagonists.
    Chen CR; Voelkel NF; Chang SW
    J Appl Physiol (1985); 1992 Nov; 73(5):1762-9. PubMed ID: 1474049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood.
    Ammit AJ; O'Neill C
    Lipids; 1991 Dec; 26(12):1189-92. PubMed ID: 1668116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.
    Filep JG; Sirois MG; Rousseau A; Fournier A; Sirois P
    Br J Pharmacol; 1991 Dec; 104(4):797-804. PubMed ID: 1667286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actions of platelet-activating factor on isolated rat hearts.
    Pugsley MK; Salari H; Walker MJ
    Circ Shock; 1991 Dec; 35(4):207-14. PubMed ID: 1663843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible or irreversible modification of [3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists.
    Domingo MT; Piro F; Broquet C; Auclair E; Chabrier PE; Braquet P
    Lipids; 1992 Aug; 27(8):582-6. PubMed ID: 1328798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor-induced coronary constriction in the isolated perfused guinea pig heart and antagonistic effects of the PAF antagonist WEB 2086.
    Felix SB; Steger A; Baumann G; Busch R; Ochsenfeld G; Berdel WE
    J Lipid Mediat; 1990; 2(1):9-20. PubMed ID: 2133268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antiplatelet agents on platelet aggregation induced by platelet--activating factor (PAF) in human whole blood.
    Chan WP; Levy JV
    Prostaglandins; 1991 Oct; 42(4):337-42. PubMed ID: 1665568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of desensitization of vasodilatation induced by platelet-activating factor in hypertensive rats.
    Kamata K; Numazawa T; Kasuya Y
    Eur J Pharmacol; 1996 Apr; 301(1-3):121-8. PubMed ID: 8773455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of leukotriene B4-induced increase in intracellular calcium ion level of human peripheral blood polymorphonuclear leukocytes by Y-24180, an antagonist of platelet-activating factor receptor.
    Komatsu H; Amano M
    Int J Immunopharmacol; 1997; 19(11-12):661-7. PubMed ID: 9669206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-activating factor (PAF-acether) and microcirculation: effect of Lyso-PAF and PAF-antagonists.
    Lagente V; Fortes ZB; Garcia-Leme J; Vargaftig BB
    Braz J Med Biol Res; 1987; 20(5):595-7. PubMed ID: 3452452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet-activating factor is mediated by leukotriene C4.
    Piper PJ; Stewart AG
    Br J Pharmacol; 1986 Jul; 88(3):595-605. PubMed ID: 3091131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist.
    Yue TL; Gleason MM; Gu JL; Lysko PG; Hallenbeck J; Feuerstein G
    J Pharmacol Exp Ther; 1991 Apr; 257(1):374-81. PubMed ID: 1850473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and cellular actions of platelet-activating factor in rat heart cells.
    Massey CV; Kohout TA; Gaa ST; Lederer WJ; Rogers TB
    J Clin Invest; 1991 Dec; 88(6):2106-16. PubMed ID: 1661298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor inhibits proteoglycan synthesis and enhances neutrophil-mediated proteoglycan degradation in cartilage explants.
    Kowanko IC; Bates EJ; Ferrante A
    Arthritis Rheum; 1992 Aug; 35(8):918-25. PubMed ID: 1322671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.